Abstracts

Search by keyword or author name.

Filter

Study

Conference

Showing 800 abstracts.

Lopinavir pharmacokinetic (PK) maturational changes and variability in HIV-infected infants beginning Kaletra (LPV/r) therapy at < 6 weeks (WK) of age.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Study

P1030

Authors

Edmund Capparelli, Jorge Pinto, Brian Robbins, Carmelita Alvero, Ram Yogev, Paul Palumbo, John H. Rodman, Barbara E. Heckman, Ellen Gould Chadwick

Nelfinavir pharmacokinetics with an increased dose during the first two weeks of life.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Study

P1043/HPTN 040

Authors

Mark Mirochnick, Karin Alvarenga-Hyldgaard Nielsen, Jose Henrique Pilotto, Jorge Pinto, Valdilea V. Santos, Diane Holland, Heather D. Watts, John ( Jack ) Moye, Lynne M. Mofenson, Yvonne J. Bryson

Augmentation of HIV-1 specific cell-mediated immune responses following vaccination with recombinant modified vaccinia ankara (MVA)-fowlpox (FP) vaccines in HIV-1-infected young adults on suppressive antiretroviral (ARV) therapy.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Study

P1059

Authors

Thomas C. Greenough, Coleen K. Cunningham, Margaret McManus, Lawrence Fox, Petronella Muresan, Deborah Persaud, Dennis Panicali, John L. Sullivan, Katherine Luzuriaga

Treatment responses to atazanavir-containing HAART in a drug-naive paediatric population in South Africa.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Study

P1020A

Authors

Tammy Meyers, Richard M. Rutstein, Pearl Samson, Avy Violari, Jennifer J. Kiser, Courtney V. Fletcher, Terence Fenton, Lynne M. Mofenson, Bobbie L. Graham, Steven M. Schnittman, Maria-Arantxa Horga, Grace M. Aldrovandi

Genetic variants of toll-like receptors-2, -4, and -9 are not associated with HIV-1 disease in children.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Authors

Kumud K. Singh, Ping Ruan, Terence Fenton, Stephen A. Spector

Dried blood spots and the ultra-sensitive p24 antigen assay for the diagnosis of perinatal HIV infection.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Authors

Ada Cachafeiro, Glenn Sherman, A. Sohn, C. Beck-Sague, Susan A. Fiscus

Analysis of NVP resistance in Ugandan infants who were HIV-infected despite receiving single-dose nevirapine vs. single-dose NVP plus up to 6 weeks of daily NVP to prevent HIV vertical transmission.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Authors

Jessica D. Church, S. Omer, Laura A. Guay, Wei Huang, Philippa Musoke, Francis Mmiro, Brooks Jackson, Susan H. Eshleman

A low-cost real-time PCR assay for HIV-1 diagnosis and quantification using dried blood spots.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Authors

S. Trzmielina, Nishaki Mehta, M. Eliot, Aletta B. Nonyane, Andrea S. Foulkes, John L. Sullivan, Katherine Luzuriaga, Mohan Somasundaran

Nevirapine exposure in Thai children receiving an adult or pediatric fixed-dose combination of stavudine (d4T), lamivudine (3TC) and nevirapine (NVP).

Conference

15th Conference on Retroviruses & Opportunistic Infections

Study

P1056

Authors

Kulkanya Chokephaibulkit, Tim Roy Cressey, Wasana Prasitsuebsai, Nirun Vanprapar, Tawee Chotpitayasunondh, Koen Frederix, Ram Yogev, Edmund Capparelli

Safety and analyses of very low-level viremia during therapeutic HIV-1 immunizations in young adults on HAART: long-term persistence of dominant plasma clones derived from residual replication-competent virus in CD4+ T cells.

Conference

15th Conference on Retroviruses & Opportunistic Infections

Study

P1059

Authors

Carlum Shiu, Coleen K. Cunningham, Carrie Ziemniak, Petronella Muresan, Lawrence Fox, Aditya Gaur, Irma L. Febo Rodriguez, Katherine Luzuriaga, Deborah Persaud

Lopinavir pharmacokinetic (PK) maturational changes and variability in HIV-infected infants beginning Kaletra (LPV/r) therapy at &lt; 6 weeks (WK) of age.

Conference

Study

Authors

Nelfinavir pharmacokinetics with an increased dose during the first two weeks of life.

Conference

Study

Authors

Augmentation of HIV-1 specific cell-mediated immune responses following vaccination with recombinant modified vaccinia ankara (MVA)-fowlpox (FP) vaccines in HIV-1-infected young adults on suppressive antiretroviral (ARV) therapy.

Conference

Study

Authors

Treatment responses to atazanavir-containing HAART in a drug-naive paediatric population in South Africa.

Conference

Study

Authors

Genetic variants of toll-like receptors-2, -4, and -9 are not associated with HIV-1 disease in children.

Conference

Authors

Dried blood spots and the ultra-sensitive p24 antigen assay for the diagnosis of perinatal HIV infection.

Conference

Authors

Analysis of NVP resistance in Ugandan infants who were HIV-infected despite receiving single-dose nevirapine vs. single-dose NVP plus up to 6 weeks of daily NVP to prevent HIV vertical transmission.

Conference

Authors

A low-cost real-time PCR assay for HIV-1 diagnosis and quantification using dried blood spots.

Conference

Authors

Nevirapine exposure in Thai children receiving an adult or pediatric fixed-dose combination of stavudine (d4T), lamivudine (3TC) and nevirapine (NVP).

Conference

Study

Authors

Safety and analyses of very low-level viremia during therapeutic HIV-1 immunizations in young adults on HAART: long-term persistence of dominant plasma clones derived from residual replication-competent virus in CD4+ T cells.

Conference

Study

Authors

Lopinavir pharmacokinetic (PK) maturational changes and variability in HIV-infected infants beginning Kaletra (LPV/r) therapy at < 6 weeks (WK) of age.